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Abstract 
 
Adenosine, acting on A2A adenosine receptors, regulates addictive processes induced by drugs 
of abuse. The present study investigates the role of A2A adenosine receptors in neurochemical 
and behavioural responses to an acute cocaine challenge. 
Changes in the extracellular levels of dopamine in the nucleus accumbens of mice 
lacking A2A adenosine receptors and wild type littermates after an acute cocaine (20mg/kg) 
administration were evaluated by in vivo microdialysis studies. Locomotor effects induced by 
cocaine were measured during the microdialysis procedure. 
Cocaine-evoked increases in extracellular dopamine were not sustained in mice 
lacking A2A receptors in comparison to wild-type mice (P<0.05). Cocaine administration 
significantly increased ambulatory activity in both genotypes. However, overall locomotor 
activity was further increased whilst rest and small local movement measures were 
significantly attenuated in the A2A receptor knockout mice compared to wildtype littermates 
(P<0.05). 
Our findings support an important role for adenosine A2A receptor in modulating the 
acute effects of cocaine, as demonstrated by the decrease in cocaine-evoked dopaminergic 
transmission in the nucleus accumbens. Furthermore, the results support an important 
antagonistic role of A2AR in vivo in regulating psychostimulant-induced hyperlocomotion. 
 
 
Abbreviations: A2A adenosine receptors, A2AR; central nervous system, CNS; dopamine, DA; 
electrochemical, EC; high-performance liquid chromatography, HPLC; knockout, KO; 
nucleus accumbens, NAc; R, receptor; subcutaneous, s.c.; wild type, WT . 
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Introduction 
 
Adenosine, an endogenous neuromodulator, has been implicated in a number of 
pathophysiological processes, including drug addiction (Hack and Christie 2003). Adenosine 
exerts its biological effects through the activation of four G-protein coupled receptor types: 
A1, A2A, A2B and A3 (Fredholm et al. 2001). A2A receptors (A2AR) are highly expressed in the 
CNS; their distribution is restricted to areas involved in the control of motivational responses, 
such as the dorsal (caudate-putamen; CPu) and the ventral striatum, including the nucleus 
accumbens (NAc) and olfactory tubercules (OT) (Johansson et al. 1997; Moreau and Huber 
1999).  
The role of mesolimbic dopamine (DA) in reinforcing behaviours and reward has been 
extensively reported (Di Chiara and Imperato 1988; Koob 1992; Everitt et al. 1999) and 
adenosine regulates dopaminergic transmission through the activation of A1 and A2A 
receptors. A2AR are expressed on somatodendritic sites of striatopallidal neurons and are co-
localised with D2-like receptors and type I metabotropic glutamate receptors (Schiffmann et 
al. 1991; Fink et al. 1992; Ferre et al. 1997; Ferre et al. 2002). There is evidence to support a 
direct physical interaction between A2A and D2/3 receptors, and the existence of A2A-D2 
heteromeric receptor complexes with reciprocal antagonistic interactions being reported. 
InadditionIn addition, A2A-mGluR5 heterometric complexes with synergistic agonistic 
interactions have also been described (Ferre et al. 1999; Ferre et al. 2002; Fuxe et al. 2005; 
Torvinen et al. 2005).  
Mice globally lacking the A2AR have demonstrated altered neurobiological and 
behavioural responses to opioids, cannabinoids and psychostimulants. Naloxone-precipitated 
withdrawal after chronic morphine administration, leads to an increase of withdrawal signs in 
A2AR knockout (A2AR KO) mice in comparison to wildtype (WT) littermates (Berrendero et 
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al. 2003; Bailey et al. 2004). Furthermore, Mu-opioid receptor (MOR) stimulated [35S]GTPS 
binding reveals a significant increase in MOR functional activation in the NAc of withdrawn 
A2AR KO mice (Bailey et al. 2004). However, the rewarding and aversive responses induced 
by an acute morphine challenge are absent in these mice (Castane et al, 2008), suggesting that 
the A2AR receptor has a differential role in somatic and motivational effects of morphine 
addiction. The rewarding properties of nicotine as measured by condition-place preference 
(CPP) and dopaminergic neurotransmission are blunted in A2AR KO mice (Castane et al. 
2006).Moreover, 9-tetrahydrocannabinol induced reward and aversion (CPP) are abolished 
whereas rimonabant-precipitated 9-tetrahydrocannabinol withdrawal is reduced in mice 
lacking the A2AR (Soria et al. 2004).      
In addition, the response to psychostimulants is altered in mice lacking A2A 
Rreceptors. Contrary to pharmacological data (Filip et al. 2006), studies using A2AR KO mice 
generated on 129-Steel or hybrid C57BL/129-Steel genetic backgrounds found the lack of 
A2AR receptors attenuates ambulatory activity in mice induced by amphetamine and cocaine. 
Moreover, amphetamine-induced behavioural sensitisation and changes in striatal dynorphin 
mRNA levels are abolished in A2AR KO mice (Chen et al. 2000; Chen et al. 2003). 
Interestingly, mice with a selective genetic deletion of the A2AR in the striatum are found to 
be more representative of pharmacological challenges and express the opposite phenotype to 
mice with fore-brain specific deletion when challenged with cocaine or phencyclidine (Shen 
et al. 2008). Investigations using A2AR KO mice generated on the outbred CD-1 background 
(Ledent et al. 1997) show a significant difference in cocaine maintained operant self-
administration between WT and A2AR KO mice, with KO mice displaying a significantly 
lower cocaine intake and a significantly lower breaking point as measured by a progressive 
ratio schedule. This suggests that the reinforcing efficacy of cocaine is decreased in A2AR KO 
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mice. These studies indicate an important role for the adenosine A2AR receptor in the actions 
of cocaine (Soria et al. 2006). 
To further elucidate the role of the A2AR receptor in the adenosinergic modulation of 
the rewarding properties of cocaine, the effects of acute systemic cocaine administration on 
extracellular DA in the NAc was evaluated in wildtype and mice globally lacking the A2AR 
receptor. In addition, locomotor behaviour and small local movements (stereotypy) during 
dialysis procedures were evaluated.  
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Material and Methods 
 
Drug and molecular target nomenclature conforms to Br. J. Pharmacol. Guide to Receptors 
and Channels (Alexander et al., 2008). Cocaine was purchased from Sigma Chemical Co 
(Dorset, U.K.) and was dissolved in sterile 0.9 % sterile physiological saline. 
The methods were carried out as detailed in Castane et al. 2008 and are described in 
brief below. Male Mmice lacking A2AR were generated on a CD1 background as previously 
reported (Ledent et al., 1997) and maintained at the University of Surrey. Heterozygote-
heterozygote matings of A2AR KO mice produced wild-type (WT) and KO littermates for 
subsequent experiments. All microdialysis procedures were carried out in the same building 
in which the mice were housed and in accordance with the guidelines of the UK Animal Act 
1986 (Scientific Procedures). Mice were handled for five days before starting the 
experiments. 
 
Microdialysis studies 
One day prior to microdialysis, mice (12-15 week old) were anaesthetized and a guide 
cannula (CMA 7, CMA microdialysis, Sweden) stereotaxically implanted targeting the left 
NAc core-shell border (AP: +1.5 mm, L: -0.9 mm, DV: -4.0 mm).  Microdialysis was carried 
out in freely-moving mice. Animals were equilibrated in a locomotor cage 1 hr prior to the 
start of microdialysis. A microdialysis probe (CMA/7/7, 1mm membrane), perfused with 
artificial cerebrospinal fluid (aCSF) (NaCl, 145 mM; KCL, 2.8 mM; CaCl2, 1.3 mM, MgCl2, 
1.2 mM)  at 1l.min-1, was inserted into the guide cannula.  Dialysate was collected for 2 hr 
and discarded to ensure a stable basal DA level. Subsequently, dialysate fractions were 
collected at intervals of 20 min for 100 min. Animals were then injected with saline (5 ml kg-
1, s.c.) or cocaine (20 mg kg-1, s.c) and dialysate fractions were collected for 120 min. 
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Following this, high potassium aCSF ([50mM]K+ aCSF)) was perfused and a further four 
sample fractions were collected. All sample fractions were collected directly into 35 l of 
acidic HPLC mobile phase and frozen immediately in dry ice.   
After the completion of the microdialysis procedure, mice were killed by cervical 
dislocation.Coronal cryostat sections (20 m) of brain were cut and probe placement was 
checked visually using hematoxilin and eosin histological staining. Only data obtained from 
animals with correct probe tracts were used for analysis. 
 
Dopamine Analysis 
DA concentration in the dialysate was determined by HPLC with electrochemical detection 
(Coulochem II, ESA Analytical Ltd, UK) which comprised a dual porous graphite electrode 
system (screening electrode at -70 mV and working electrode at +190 mV; guard cell at +400 
mV). A Spherisorb ODS2 analytical column (100 mm x 4.6 mm x 5mm, Waters Ltd, UK) 
with a guard column (Phenomenex, UK) were used. The mobile phase consisted of 0.05 M 
NaH2PO4, 0.8 mM OSA, 0.1 mM EDTA and 10% methanol, pH 3.3. Dialysate DA 
concentrations were quantified by external standard curve calibration, using peak area for 
quantification; data were not corrected for probe recovery. 
 
Monitoring of ambulation 
Locomotion, small local movements and resting behaviours were measured (TruScan, Bilaney 
Consultants, U.K) during the microdialysis procedure. Two sensor rings; each with 32 x 32 
photobeams, were set 2cm (horizontal activity) and 6cm (vertical activity) from the cage 
floor. Each animal’s accumulated basal activity was measured for 100min.. The acquisition 
software was paused to allow the mouse to be administered either challenge (saline or 
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cocaine) within the locomotor chamber and resumed for another 220 min to record challenge-
induced movements and movement during post-challenge high potassium evoked DA release.  
Statistical analysis 
Acute effects of cocaine on extracellular levels of DA were analysed using a multifactorial 
ANOVA with time (T), genotype (G, WT or KO) and challenge (C, saline or cocaine) as 
factors of variation, with Duncans Multiple Range post hoc analysis. Data from the high 
potassium effects on extracellular levels of DA are presented as aArea under the curve (AUC) 
values, represented as the DA increase from the basal levels. AUC was calculated by using a 
standard trapezoid method (Gibaldi and Perrier 1975) and were analyzed by using Student's t-
tests with P ≤< 0.05 as the level of significance 
 Comparison of locomotion (as absolute values, distance in mm) was made between 
treated animals, using three-way repeated measures ANOVA followed by Duncans post-hoc 
analysis, for the factors of time (T), genotype (G) and challenge (C) The significance level for 
all tests was P ≤ 0.05. The data are expressed as mean± SEM. 
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Results 
Decreased cocaine-evoked extracellular dopamine in the NAc of A2AR KO mice 
 
The extracellular levels of DA in the NAc were assessed by microdialysis in freely-moving 
WT and adenosine A2AR KO mice (n = 5 for saline-treated WT mice, n = 6 for saline-treated 
KO mice, n = 5 for cocaine-treated WT mice, n = 7 for cocaine-treated KO mice). Basal 
extracellular DA levels measured over five dialysate collections (100 min) were not 
significantly different in WT (1.37 ± 0.15 nM, n = 10) and KO mice (1.25 ± 0.16 nM, n = 13). 
No significant change in DA concentration between saline-treated WT and A2AR KO mice 
was observed. and there was no significant effect of saline treatment on extracellular DA 
levels. Administration of cocaine (20 mg kg-1, s.c.) markedly and significantly increased 
accumbal DA in both genotypes in comparison to saline-treated groups (P < 0.01), with a 
maximum effect 60mins post-injection (Fig 1a). Cocaine initially increased accumbal DA 
concentrations in WT and A2AR KO in a similar manner (0-60min post injection). Cocaine-
evoked extracellular DA was sustained in WT mice, however, there was a reduction in DA 
levels in the later fractions of cocaine-treated A2AR KO mice compared to wildtype mice and 
this achieved statistical significance (P < 0.05) at 100 and 120 min after challenge.  
Artificial CSF with a high concentration of potassium ([K+] 50mM) was infused 
through the probe 120mins after the administration of challenge. There was a marked and 
very highly significant increase in DA concentration ([DA]120mins, 140mins; P < 0.001) in the 
NAc of saline and cocaine-treated WT and KO mice ( Fig. 1b). The cocaine-treated groups 
had a lower evoked DA concentration, and the levels seen in saline or cocaine-treated KO 
mice were lower than those seen in WT mice, but these differences did not reach significance 
for the factors of treatment or genotype. 
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Altered ambulatory effects by cocaine A2AR KO mice 
 
On the day of the experiment mice were exposed to the locomotor chambers for one hour, 
before the implantation of the microdialysis probe, in order to be habituated to the test 
environment. The mice were then left for a further two hours to recover from implantation 
and to habituate to the freely-moving counter-balance arm before their basal ambulatory 
activity was measured. The mice resumed normal exploratory and sleeping behaviours (data 
not shown).  
Basal locomotor activity was similar in both genotypes.  Acute cocaine administration 
induced a marked increase in locomotor behaviour in both genotypes compared to saline 
treated groups (Fig 2a) . The cocaine-induced locomotor effect was at a maximum 40-60 min 
post injection in both WT and KO mice. ANOVA analysis showed a highly significant 
difference in locomotor activity between treatment groups (saline versus cocaine treatment) 
and significant differences over time, with a significant challenge-time interaction. Further 
post hoc (Duncan’s) analysis also indicated significant differences between genotype in 
cocaine-treated WT and A2AR KO mice; cocaine-induced locomotor activity was significantly 
higher in A2AR KO mice compared to WT mice (G (40-120mins), P < 0.05).  
The number of small local movements was similar in both naïve WT and A2AR KO 
mice. Cocaine administration induced an increase in small local movements in both 
genotypes, the effect of which was at a maximum 100min post-injection (Fig 2b).  
Comparison of treatment groups showed that there was a highly significant increase in small 
local movements in cocaine-treated WT and A2AR KO mice compared to the saline treated 
controls. Analysis also indicated a very significant challenge-time interaction. Moreover, 
further post hoc (Duncan’s) analysis showed that there was a significant difference between 
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small local movements in cocaine-treated wildtype and A2AR KO mice, with the significant 
attenuation of cocaine-induced small local movements in A2AR KO mice (G(40-100mins), P < 
0.05).   
Rest time in naïve wildtype and A2AR-/- mice was similar (Fig 2c). Cocaine 
administration significantly decreased rest time in both genotypes in comparison to saline 
treated animals. The treatment-induced decrease was at a maximum 80min post-injection, 
where there was a significant difference in rest-time between cocaine treated wildtype and 
A2AR-/- mice. Knockout mice had a significantly greater cocaine-induced decrease in rest 
time compared to treated wildtype mice (P < 0.05). 
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Discussion 
 
The aim of this study was to investigate the neurochemical response of accumbal DA 
in WT and A2AR KO mice to an acute administration of cocaine. The locomotor response of 
WT and A2AR KO mice was monitored throughout the treatment period. The findings of the 
present study indicate the presence of an altered neurochemical response to an acute cocaine 
challenge in mice lacking the A2AR receptor.  
In agreement with recent in vivo microdialysis studies, no significant difference was 
observed in the basal accumbal DA between naïve wildtype and A2AR KO mice (Castane et 
al. 2006, 2008). In the present study, an acute challenge of cocaine increased extracellular DA 
in the accumbens of WT and A2AR KO mice in a similar manner. However, the evoked 
response was not sustained in the A2AR KO mice in comparison to WT mice.  Previous 
studies (Soria et al. 2006) have reported a significantly lower intake of cocaine in A2AR KO 
mice compared to WT littermates as measured by operant behaviour maintained by i.v. 
cocaine infusions and these authors suggested that the efficacy of the reinforcing effects and 
not the acute rewarding properties of cocaine were altered in these mice. Our results showing 
that the initial level of cocaine-evoked DA is the same but the DA release is not sustained in 
KO mice support the suggestion that it is the reinforcing effects and not the initial rewarding 
properties of cocaine that are reduced in mice lacking the A2A receptor.  
The altered DAergic transmission in A2AR KO mice during the later stages of cocaine 
challenge may support a mechanism by which the lack of A2AR leads to changes in 
downstream cellular signalling. A2A and D2/3 receptors converge to modulate the effects of 
intracellular downstream signalling-pathways, by the regulation of dopamine- and cAMP-
regulated phosphoprotein of 32 kDa (DARPP-32) (Svenningsson et al. 1998; Svenningsson et 
al. 2000; Torvinen et al. 2005). Regulation of DARPP-32 has been shown to play an 
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important role in the effects of drugs of abuse (Nairn et al. 2004; Svenningsson et al. 2005; 
Zachariou et al. 2006; Borgkvist and Fisone 2007). Interestingly, DARPP-32 regulation is 
altered in A2AR KO mice (Svenningsson et al. 2000) ;and alterations in intracellular cascades 
downstream of dopamine release may affect the negative feedback mechanisms regulated by 
GABAergic medium spiny neurons. These findings support an important role of A2AR in the 
regulation of cocaine-induced accumbal DA.Our results showing that the initial level of 
cocaine-evoked DA is the same but the DA release is not sustained in KO mice when 
considered in combination with the changes in post-synaptic downstream signalling may 
contribute to changes in the reinforcing effects of cocaine in a chronic paradigm. These 
findings support an important role of A2AR in the regulation of cocaine-induced accumbal 
DA. 
The intensity of basal ambulatory activity in naive A2AR KO mice was similar to WT 
mice in all variables measured (locomotion, small local movement and rest) (data not shown). 
This is in contrast with previous reports, where A2AR KO mice were shown to have a 
hypolocomotor phenotype (Ledent et al. 1997; Soria et al. 2006). However, this is most likely 
to be due to differences in experimental paradigm, as in the aforementioned studies the 
ambulatory activity was measured directly after the initial introduction of the mice to a novel 
environment or recorded for a short experimental period (10min) after three days of short 
habituation, respectively. In the current study, the mice had an extended period of habituation 
pre- (1 hr) and post- (2 hr) probe implantation, during which mice of both genotypes 
displayed normal exploratory and sleep behaviours. In support of this, hypolocomotion was 
not observed in a study of A2AR KO mice subjected to an extended habituation period 
(120min) (Chen et al. 2000). Therefore, the hypolocomotor phenotype observed in A2AR KO 
mice in the studies by Ledent et al (1997) and Soria et al (2006) is probably due to an initial 
increased level of anxiousness to novel environments, which decreases over extended periods 
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until the behaviour is similar to that of WT littermates. Indeed studies have shown that A2AR 
KO mice have been reported to exhibit increased levels of anxiety (Ledent et al. 1997).  
 In this study cocaine-induced hyperlocomotion was significantly exacerbated in A2AR 
KO mice; this was accompanied by a decreased in cocaine-evoked small local movements and 
rest time compared to WT littermates. The increase in hyperlocomotion is in agreement with 
studies using pharmacological challenges (Poleszak and Malec 2002; Nagel et al. 2003; Filip 
et al. 2006), but in contrast to A2AR KO mice generated on in-bred hybrid backgrounds (Chen 
et al. 2000). This discrepancy could be explained by a variation in background strain upon 
which the conditional knockouts were produced. The study in question used A2AR KO mice 
generated on an mixed inbred C57Bl/6 background (Chen et al. 1999), where as the mice used 
in this study were generated on an outbred CD1 background (Ledent et al. 1997). Genetic 
strain variations have been shown to influence modifications in behavioural strategy and 
drug-induced neurochemistry (He and Shippenberg 2000; Voikar et al. 2001). Indeed, recent 
studies in hybrid 129-Steel/C57BL/6 mice with selective mutations of the A2AR in striatal 
region versus the forebrain show opposite locomotion phenotypes when challenged with 
cocaine (Shen et al. 2008). This suggests that the variation in the genetic background of these 
mice may be an important factor in explaining the discrepancies seen in acute cocaine-
induced behaviours. 
The increase in cocaine induced hyperlocotion in the A2AR KO mice supports the in 
vivo role of this receptor in the reciprocal antagonistic A2A-D2R heterodimer. The increased 
ambulation cannot be directly attributed to altered cocaine-induced levels of extracellular DA 
in the NAc of these animals. The modified ambulatory response is seen in the immediate 
stages of the cocaine-induced response; during which time there is no significant difference in 
cocaine-induced accumbal DA levels between KO and WT animals and difference is 
sustained during the reduced extracellular DA concentrations in the latter stages of the 
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cocaine-induced response in the KO mice. Increases in accumbal DA evoked by high 
potassium aCSF did not lead an increase locomotor activity.  Recent evidence has suggested a 
role for the NAc in cocaine-induced locomotor activity, with emphasis on the accumbal core 
(D'Souza and Duvauchelle 2006; Sellings et al. 2006). Since the sampling region of each 
accumbal probe in the current study spanned the core-shell boarder it is not possible to draw 
inferences about the role of the individual subregions of the NAc. Blockade of A2AR receptors 
in the NAc has been shown to increase locomotor activity and this is thought to be due to 
alterations in the A2AR-D2R relationship. The loss of the A2A receptor in the accumbal core 
may relieve a tonic inhibition of D2 receptors leading to the increase in locomotor activity in 
the A2AR KO mouse. 
In conclusion, our findings support an important role for adenosine A2A receptor in 
modulating the acute effects of cocaine, as demonstrated by the decrease in cocaine-evoked 
DAergic transmission in the nucleus accumbens. The results also aid in the elucidation the 
mechanisms regulating the reduced reinforcing efficacy of cocaine in A2AR KO mice. 
Furthermore, the results support an important antagonistic role of A2AR in vivo in regulating 
psychostimulant-induced hyperlocomotion. However, the potentiation of cocaine-induced 
hyperlocotion could not be attributed to alterations in accumbal DAergic transmission, 
suggesting the role of separate neuronal substrates in the regulation of cocaine-evoked 
DAergic and hyperlocomotion. 
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Legends of the Figures  
Figure 1. Effects of the systemic cocaine administration on dopamine levels in the 
nucleus accumbens of A2AR knockout and wildtype mice.  
A) A) Extracellular dopamine levels (nM) in the nucleus accumbens of freely-moving WT 
and A2AR KO mice during the baseline period. Open shapes (□) indicate data from wildtype 
animals n=10; closed   shapes (■)  indicate data from knockout  animals n=13. Data are 
expressed as mean ± SEM.   
 
B) Dopamine levels in the nucleus accumbens of freely-moving WT and A2AR KO mice 
treated with either saline  (5ml/kg s.c.)  or   cocaine  (20mg/kg s.c.). Open shapes indicate 
data from wildtype animals, □ WT saline treated n = 5, ○ WT cocaine treated n = 5; closed   
shapes   indicate data from knockout  animals, ■ A2AR KO saline treated n = 6, ● A2AR KO 
cocaine treated n = 7. Data are expressed as mean ± SEM.  Post-hoc (Duncan’s) analysis 
indicates significant differences within the factor of fraction between WT cocaine treated and 
A2AR KO cocaine treated mice *P < 0.05. 
 
CB) High potassium [50mM] evoked extracellular dopamine release calculated as area under 
the curve (AUC) in the NAc of freely moving WT and A2AR KO mice treated with either 
saline (5ml/kg s.c.) or cocaine (20mg/kg s.c.).  
Data from saline treated mice are indicated by the open bar and data from cocaine treated 
mice are represented by the closed shaded bar. Data are expressed as mean ± SEM, WT saline 
treated n = 4, WT cocaine treated n = 5, A2AR KO saline treated n = 5, A2AR KO cocaine 
treated n = 6. Two-way ANOVA indicated there were no significant differences between 
genotypes or treatments (P > 0.05). 
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Figure 2. Ambulatory movement induced by cocaine in A2AR knockout and wildtype 
mice. 
A) Locomotor activity measured as ambulatory distance (the sum of all vectored X-Y 
coordinate changes less the vectored distance in small local movements (stereotypy) in WT 
and A2AR KO mice treated with either saline  (5ml/kg s.c.)  or  cocaine  (20mg/kg s.c.). Open  
shapes  indicate data from WT animals, □WT saline treated n=6, ○WT cocaine treated n=7; 
closed shapes indicate data from knockout animals, ■A2AR KO saline treated n=5, ●A2AR KO 
cocaine treated n=5. Data are expressed as mean ± SEM.  Post-hoc (Duncan’s) analysis 
indicates significant differences within the factor of time between WT cocaine treated and 
A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P <0.001. 
 
B) Small local moves in WT and A2AR KO mice treated with either saline (5ml/kg s.c.) or 
cocaine (20mg/kg s.c.). Open shapes indicate data from wildtype animals, □WT saline treated 
n=6, ○WT cocaine treated n=7; closed   shapes   indicate data from knockout   animals, ■ 
A2AR KO saline treated n=5, ●A2AR KO cocaine treated n=5. Data are expressed as mean ± 
SEM.  Post-hoc (Duncan’s) analysis indicates significant differences within the factor of time 
between WT cocaine treated and A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P 
< 0.001. 
  
C) Rest time (secs) measured as the total session time less all vectored X-Y coordinate 
changes.Open  shapes  indicate data from WT animals, □WT saline treated n=6, ○WT cocaine 
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treated n=7; closed shapes indicate data from knockout animals, ■A2AR KO saline treated 
n=5, ●A2AR KO cocaine treated n=5. Data are expressed as mean ± SEM.  Post-hoc 
(Duncan’s) analysis indicates significant differences within the factor of time between WT 
cocaine treated and A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P <0.001. Mice 
were treated with either saline (5ml/kg s.c.) or cocaine (20mg/kg s.c.). 
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